𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The long-term effect of radiotherapy on the immune status of patients cured of a gynecologic malignancy

✍ Scribed by M. Halili; J. Bosworth; S. Romney; M. Moukhtar; N. A. Ghossein

Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
291 KB
Volume
37
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Toxicity and long term effects of a subl
Toxicity and long term effects of a sublethal concentration of cadmium on the growth of the fingerlings ofOphiocephalus punctatus (BL.)
✍ Shukla, J. P. ;Pandey, K. πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 243 KB πŸ‘ 1 views

The LC, for exposure of 48 and 96 h is 34.64 and 18.6 mg/l Cd2+, respectively. During the exposure to 3.5 mg/l Cd'+ from the 13th day significant differences of length and mass occur with respect to the control. Over a total of 31 days of experiment the reduction of growth rates is 11 "/,, for the l

Long-term effect of the complement inhib
Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria
✍ Peter Hillmen; Modupe Elebute; Richard Kelly; Alvaro Urbano-Ispizua; Anita Hill; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 140 KB πŸ‘ 1 views

## Abstract Paroxysmal nocturnal hemoglobinuria (PNH) is a debilitating and life‐threatening disease in which lysis of PNH red blood cells frequently manifests with chronic hemolysis, anemia, and thrombosis. Renal damage in PNH is associated with chronic hemosiderosis and/or microvascular thrombosi

The impact of stage and histology on the
The impact of stage and histology on the long-term clinical course of 163,808 patients with breast carcinoma
✍ John W. Gamel; John S. Meyer; Eric Feuer; Barry A. Miller πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 491 KB

## BACKGROUND. Stage and histologic type have a significant impact on the long term clinical course of breast carcinoma. Clinical course is governed by two components: likelihood of cure and median tumor-related survival time among uncured patients. Estimates of these components can be derived only